Illumina’s accelerator has an impressive 93 percent follow-on funding rate — here’re its latest picks

14:49 25.06.2020
Since its launch in 1998 Illumina and its genetic analysis toolkits and services have become an essential component of the new biological manufacturing and therapeutic development industries which have emerged in the last twenty five years. And for the past six years the company has attempted to encourage the development of the industry through an […]...
  260